1Saleh HA, Masood S,Khatib G. Percutaneuous and intraoperative aspiration biosy of pancreatic neuoendocrine tumors: cytomorphologic study with an immunocytochemical contri- bution[J]. Acta Cytol, 1996, 40(2):182- 190.
2Marcos HB, Libutti SK. Alrxander HR, et al. Neuroendocrine tumors of the pancreas in yon Hippel - Lindau Disease: spectrum of appearances at CT and MR imaging with histologic comparison [ J ]. Radiology, 2002, 225 ( 3 ) : 751 - 758.
3Faiss S,pape UF, Bohmig M, et al. Prostective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenpancreatic tumors-the International Lanreotide and Interferon Alfa Study Group [J] .J Clin Oncol, 2003,21 (14) :2689 - 2696.
4Rindi G, Kloppel G. Endocrine tumors of the gut and pancreas tumor biology and classigication [J]. Neuroendocrinology,2004,80(Suppl 1 ) : 12 - 15.
5Schipper ML, Weber A, Behe M, et al. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumou cells[ J]. Cancer Res, 2003, 63(6) : 1333 - 1338.
6Tezel E, Nagasaka T, Nomoto S, et al. Neuroendoerine- like differentiation in patients with pancreatic carcinoma[J].Cancer, 2000,89(11):2230 - 2236.
7Akerstrom G, Hellman P, Hessman O, et al. Surgical treatment of endocrine Pancreatic tumors [ J ]. Neuroendocrinology, 2004, 80 (Suppl) : 62- 66.
8Wang I, Zhao YP, Lee Cl,et al. Diagnosis and treatment of maliganant pancreatic endocrine tumor[J]. Chin Med Sci J [J]. 2004,9(2) : 130 - 133.
